IGF2 and hepatocellular carcinoma: Since hepatocytes overexpressing IGF-2 may be prone to acquire additional genetic changes, determination of hepatic IGF-2 levels and, in particular, morphologic assessment of IGF-2 overexpression may be indicators of an increased risk to develop HCC.